CALL - SPRINTER OPEN END - MERCK & CO. | Market Closed - Deutsche Boerse AG 01:43:22 2024-07-16 pm EDT | ||
| 3.01 EUR | -3.53% |
|
| Current month | -9.34% | ||
| 1 month | -10.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 3.01 | -3.53% |
| 24-07-15 | 3.12 | -2.50% |
| 24-07-12 | 3.2 | +0.63% |
| 24-07-11 | 3.18 | +1.27% |
| 24-07-10 | 3.14 | +4.67% |
Delayed Quote Deutsche Boerse AG
Last update July 16, 2024 at 01:43 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM5436 |
| ISIN | DE000VM54369 |
| Date issued | 2023-11-29 |
| Strike | 93.91 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.98 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.79 € |
|---|---|
| Lowest since issue | 1.02 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.4
USD
Average target price
142.5
USD
Spread / Average Target
+13.63%
- Stock Market
- Certificates
- Certificat
